Sodium Lactate Ringer′s Injection Medcine Infusion

• Customization: Available
• Application: Internal Medicine
• Usage Mode: Injection
• Model NO.: sodium lactate ringer′s injection
• Suitable for: Elderly, Children, Adult
• State: Liquid
• Shape: Injection
• Type: Inorganic Chemicals
• Pharmaceutical Technology: Chemical Synthesis
• Specification: 100mL~1000mL
• Trademark: SHIMEN
• Origin: Shijiazhuang
• Production Capacity: 1 Billion / Year

Product Description

Basic Info.

Model NO.	250ml 500ml 1000ml
Drug Reg./Approval No.	20044961
Specification	250ml 500ml 1000ml
Origin	Hebei
Production Capacity	1000000
Pharmaceutical Technology	Chemical Synthesis
Transport Package	Plastic Bottle
Trademark	SHIMEN

Product Description

 

Ringer Lactate Injection

Product name: Ringer Lactate Intravenous Infusion
Main ingredients and chemical name: every 1000ml contain: Sodium Lactate 3.20g   sodium chloride 6.00g  potassium chloride 0.40g  Calcium chloride (CaCl2·dihydrate) 0.27g
Character The product is a colorless clear liquid.
Pharmacology and toxicity In the natural case our blood contain a little lactic acid, it is mainly produced by dextrose or hepatin through zymohydrolysis happening in muscle, skin, brain and cell. After the production of lactate, lactic acid will be translated into hepatin or pyruvic acid , or come into tricabroxylic acid circle , be decomposed to water and carbon dioxide. So the last metabolize production is sodium bicarbonate, it can correct metabolizable acid toxicosis. When the product is indicated for hyperpotassaemia following   acidosis , sodium lactate can correct acid toxicosis, and make the potassium come into the cell from blood or extracellular fluid. The main viscera that can decompose lactic acid is liver and kidney. When the metabolize of lactic acid is abnormal or out of gear, the curative effect is not very good.
Indications
It is indicated to adjust the equilibrium of humour electrolyte acid and alkali, Used for metabolic acid toxicosis or dehydration caused by metabolic acid toxicosis.

Shijiazhuang No.4 Pharmaceutical Co., Ltd. was established in 1948, now it is a large-sized foreign invested enterprise and comprehensive medicine manufacturer in China, the capital is USD58 million, and with more than 3000 employees. The company can manufacture 7 series medicines of more than 100 kinds and specifications including infusions, capsules, granules, tablets, oral liquids and etc with GMP approval by SFDA of China. For the key product of large volume I.V solution, the yearly output has reached more than 1200 million bottles including 40 million bottles packing with the soft plastic bottles in the dosage of 500 ml/ 250 ml /100ml. Some index such as quality, variety, and yearly output are all in the leading position of this field in China.  
The products have been sold to some countries and regions in South America, Africa, and Asia.

Detailed Photos

Certifications